Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
NCT01078909Phase 3Completed
- Sponsor
- The Pennsylvania State University
- Start
- Oct 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in inflammation, cardiovascular disease (CVD), sponsored by The Pennsylvania State University. Started Oct 2011; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
inflammationcardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01078909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078909.